Psychiatry and Neurology, Neurology · Los Angeles, CA
NPI
1164440442
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Medical Plaza, #b200
Los Angeles, CA, 90095
Phone (310) 794-1195
Groups this clinician bills Medicare through
Medicare paid, 2024
$54K
466 services
Medicare patients, 2024
213
Average age 63
Drug cost, 2024
$1.4M
1,503 prescriptions
Company payments, 2025
$197K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John M Stern was code 95720 (neurologic), 153 times for 62 patients. In total John M Stern billed 466 services in 20 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 153 | 62 | $170.47 | $26K |
| 99215 Office E&M - Established | Office | 94 | 59 | $127.72 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 57 | 26 | $64.44 | $3,673 |
| 95816 Neurologic | Facility | 47 | 46 | $45.24 | $2,126 |
| 99223 Hospital E&M - Initial | Facility | 29 | 27 | $138.63 | $4,020 |
| 99214 Office E&M - Established | Office | 17 | 14 | $86.68 | $1,474 |
| 95970 Electrical Nerve Conductivity | Office | 14 | 13 | $10.10 | $141 |
| 95819 Neurologic | Facility | 14 | 13 | $43.87 | $614 |
By year: 2022 $77K for 626 services; 2023 $71K for 591 services; 2024 $54K for 466 services.
Medicare prescription drug claims, 2024
In 2024, the drug John M Stern prescribed most often to Medicare patients was Lacosamide, with 198 prescriptions and refills. In total John M Stern wrote 1,503 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lacosamide Generic | 198 | 249 | 26 | $29K |
| Levetiracetam Generic | 136 | 209 | 20 | $9,540 |
| Xcopri Cenobamate | 117 | 123 | 15 | $230K |
| Briviact Brivaracetam | 106 | 124 | 13 | $271K |
| Clobazam Generic | 78 | 78 | 11 | $15K |
| Lamotrigine Generic | 60 | 123 | Under 11 | $969 |
| Vimpat Lacosamide | 52 | 60 | Under 11 | $103K |
| Topiramate Generic | 50 | 78 | Under 11 | $904 |
| Lamotrigine Er Lamotrigine | 50 | 73 | Under 11 | $6,794 |
| Levetiracetam Er Levetiracetam | 39 | 61 | Under 11 | $3,138 |
| Zonisamide Generic | 37 | 51 | Under 11 | $1,425 |
| Keppra Xr Levetiracetam | 34 | 63 | Under 11 | $83K |
| Epidiolex Cannabidiol (Cbd) | 33 | 34 | Under 11 | $144K |
| Phenobarbital Generic | 31 | 39 | Under 11 | $430 |
| Lamictal Xr Lamotrigine | 31 | 51 | Under 11 | $130K |
Brand drugs: 623 claims; generic drugs: 849 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John M Stern $197K ($197K in general payments such as food, travel and fees) from 8 companies. The largest payer was LivaNova USA, Inc. with $50K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.